Accenture 2016
Consumer Survey on
Patient Engagement
Global Report
Overview
•
Accenture commissioned a seven-country survey of 7,840 consumers ages
18+ to assess their attitudes toward health, the healthcare system, electronic
health records, healthcare technology and their healthcare providers’
electronic capabilities.
•
The online survey included consumers across seven countries: Australia (1013),
Brazil (1006), England (1009), Norway (800), Saudi Arabia (852), Singapore
(935) and the United States (2225).
•
The seven-country survey was conducted by Nielsen on behalf of Accenture
between November 2015 and January 2016 (The US survey was conducted
online between November 13 and December 2, 2015).
•
The analysis provided comparisons by country, sector, age and use.
•
Where relevant, the survey uses select findings from the 2015 Accenture
Doctors Survey to compare the doctor and consumer responses.
Copyright © 2016 Accenture. All rights reserved.
2
Method
With whom did Accenture work to conduct the
quantitative survey?
What did we do to ensure balance and a
representative sample?
Accenture worked with Nielsen, who was responsible for the
entire project including recruitment, screening of respondents,
questionnaire development, analysis and report development.
Data were weighted to be nationally representative of the general
population in each country (or the online population in the case
of Brazil*).
• In Australia, data were weighted by education, age by sex,
region, and income
• In Brazil, data were weighted by sex, age, region, income
socioeconomic group, internet connection type, and
whether an online buyer
• In England, data were weighted by region, education, age
by sex, and hours online
• In Norway, data were weighted by age by gender,
education, income, region, and household size
• In Saudi Arabia, data were weighted by age by sex,
nationality, and region
• In Singapore, data were weighted by age by sex, ethnicity,
and household income
• In the US, data were weighted by education, age by sex,
race/ethnicity, region, and income to be nationally
representative of the general population. However, because
2014 data were not weighted, all data for trended questions
are not weighted. This is indicated on each slide.
Who was surveyed?
Approximately, n=7840 consumers total, ages 18+, in the US,
Australia, Brazil, England, Norway, Saudi Arabia, and Singapore
who agreed to take part in the survey.
How did Accenture recruit study participants?
Respondents were contacted through direct email invitations and
notifications; respondents are able to follow a unique link to the
survey and complete it anonymously.
Are we confident in the quality of the respondents and that they
meet the study criteria?
All participants are consumers, ages 18+, residing in the countries
specified and nationally representative on age and gender.
Participants’ details are double verified and were rescreened for
this study to ensure participant quality.
Was the questionnaire translated into the appropriate native
language?
Yes, the survey was translated into: Portuguese (Brazil);
Norwegian (Norway); Arabic (Saudi Arabia). English (localized)
was used for England, Australia, Singapore, and Saudi Arabia
(English and Arabic options offered).
Copyright © 2016 Accenture. All rights reserved.
*Brazil weighted to online population because the internet penetration is still relatively
low and with online sample you cannot reach a sufficiently representative sample for
general population representation.
3
Research Results:
Key Findings
4
Most consumers with EHRs have not accessed their
records
Have Ever Accessed EHR
14%
9%
14%
30%
13%
13%
25%
33%
31%
27%
25%
27%
44%
86%
45%
91%
86%
70%
87%
87%
75%
67%
69%
73%
75%
56%
73%
55%
2015
2014 2015
2014 2015
2014 2015
2014 2015
2015
2014 2015
2014 2015
Global
Australia
Brazil
England
Norway
Saudi Arabia
Singapore
US
No
Yes
BASE: HAS EHR: Global 2016 n=5408;Australia 2014 n=764,2016 n=657; Brazil 2014 n=804,2016 n=647; England 2014 n=811,2016 n=677;
Norway 2014 n=669,2016 n=632; Saudi Arabia 2016 n=544; Singapore 2014 n=617,2016 n=597; US 2014 n=1585,2016 n=1654;
Q820. (Q158.) Have you ever accessed your electronic health records?
NOTE: unweighted data
Copyright © 2016 Accenture. All rights reserved.
5
Among consumers with EHRs, lab work and
prescription history are most commonly available
EHR Data Have Access To
Global
Australia
Brazil
England
Norway
Saudi
Arabia
Singapore
US
2016
2014
2016
2014
2016
2014
2016
2014
2016
2016
2014
2016
2014
2016
Lab work and
blood test
results
35%
7%
19%
42%
43%
7%
13%
13%
22%
48%
16%
34%
24%
48%
Prescription
medication
history
32%
10%
18%
26%
33%
10%
22%
15%
25%
35%
16%
33%
23%
44%
26%
8%
11%
15%
27%
7%
11%
7%
17%
36%
16%
33%
15%
36%
26%
8%
14%
20%
25%
7%
13%
14%
23%
40%
14%
31%
15%
33%
25%
7%
13%
12%
17%
6%
12%
13%
20%
30%
8%
26%
16%
37%
26%
8%
19%
28%
30%
5%
11%
12%
21%
38%
15%
34%
13%
29%
24%
9%
14%
16%
17%
4%
7%
8%
13%
33%
22%
37%
18%
35%
1%
44%
1%
79%
1%
66%
0%
33%
2%
35%
1%
79%
1%
62%
0%
74%
2%
58%
3%
20%
1%
56%
2%
36%
1%
61%
0%
35%
Personal
profile
information
Physician
notes from
visits or
about my
medical
condition
Immunization
status
X-rays or
nuclear
imaging
results
Billing
information
Other
Don’t know
BASE: HAS EHR : Global 2016 n=5408;Australia 2014 n=1020,2016 n=657; Brazil 2014 n=1015,2016 n=647; England 2014 n=1019,2016 n=677; Norway
2014 n=806,2016 n=632; Saudi Arabia 2016 n=544; Singapore 2014 n=806,2016 n=597; US 2014 n=2011,2016 n=1654;
Q845. (Q160.) Which of the following data in electronic health records do you have access to?
NOTE: unweighted data
Copyright © 2016 Accenture. All rights reserved.
6
Consumers access their EHR to stay informed and
satisfy curiosity
Primary Reason Access EHR
Global
To keep me
informed
Curious to
know what is
in medical
record
Make sure
medical
record is
accurate
Track the
progression
of medical
illness or
disease
Help make
medical
decisions
Other
Australia
Brazil
England
Norway
Saudi
Arabia
Singapore
US
2016
2014
2016
2014
2016
2014
2016
2014
2016
2016
2014
2016
2014
2016
34%
37%
22%
32%
39%
37%
28%
35%
25%
23%
26%
27%
43%
41%
23%
18%
24%
15%
15%
15%
26%
24%
30%
23%
15%
19%
17%
25%
19%
25%
31%
17%
19%
20%
13%
21%
25%
20%
21%
21%
18%
16%
12%
6%
14%
24%
15%
12%
10%
8%
6%
13%
20%
22%
12%
10%
9%
13%
5%
12%
11%
16%
20%
10%
8%
20%
18%
11%
9%
6%
2%
2%
4%
1%
0%
0%
2%
2%
6%
1%
0%
0%
2%
2%
BASE: HAS ACCESSED EHR : Global 2016 n=1611;Australia 2014 n=106,2016 n=95; Brazil 2014 n=357,2016 n=214; England 2014 n=75,2016 n=89;
Norway 2014 n=89,2016 n=159; Saudi Arabia 2016 n=166; Singapore 2014 n=165,2016 n=150; US 2014 n=434,2016 n=738;
Q821. (Q169. What is the primary reason you access your electronic health records?
NOTE: unweighted data
Copyright © 2016 Accenture. All rights reserved.
7
Lab work and blood test results in EHRs are most
helpful for managing health
EHR Data that Most Helps Manage Health
Global
Australia
Brazil
England
Norway
Saudi
Arabia
Singapore
US
Lab work and blood test
results
34%
28%
42%
14%
15%
34%
28%
41%
Physician notes from my
visits or about my
medical condition
26%
22%
23%
22%
34%
27%
34%
24%
Prescription medication
history
11%
17%
13%
26%
14%
7%
10%
9%
Personal profile
information
6%
5%
6%
5%
3%
11%
6%
5%
Immunization status
5%
7%
5%
3%
9%
4%
4%
5%
X-rays or nuclear imaging
results
6%
4%
8%
4%
10%
6%
6%
5%
Billing information
5%
4%
2%
3%
6%
6%
7%
5%
Other
0%
0%
0%
1%
0%
0%
0%
0%
Don’t know
7%
12%
1%
22%
10%
5%
5%
6%
BASE: KNOWS WHAT DATA HAVE ACCESS TO IN EHR, HAVE ACCESS TO MULTIPLE TYPES OF DATA: Global Total n= 2309; Australia n= 161; Brazil n= 314;
England n= 138; Norway n= 199; Saudi Arabia n= 306; Singapore n= 285; US n= 906
Q850. Which of the following types of information in your electronic health record most helps you manage your health?
Copyright © 2016 Accenture. All rights reserved.
8
Consumers and doctors agree that patients should have
access to EHRs, but consumers want full access, while
doctors prefer limited access
Level of Access Patient Should Have to EHR
Any
Access
98%
98%
84%
99%
85%
96%
92%
98%
87%
97% 97%
97%
11%
22%
25%
85%
88%
2%
Global
10%
2%
84%
82%
73%
16%
Australia
15%
15%
1%
Brazil
18%
92%
70%
60%
13%
92%
75%
81%
84%
99%
17%
23%
26%
87%
61%
70%
22%
15%
4%
14%
8%
15%
13%
3%
2%
England
No access
74%
73%
Norway
Limited Access
5%
Saudi Arabia
14%
2%
7%
1%
Singapore
7%
US
Full Access
BASE: ALL QUALIFIED RESPONDENTS: Global Total n= 7840; Australia n= 1013; Brazil n= 1006; England n= 1009; Norway n= 800; Saudi Arabia n= 852; Singapore n= 935; US n= 2225
Q830. (D905/710)
What level of access should you as a patient have to your electronic health record, created by your physician?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
9
Consumers who want EHR access want to see exactly
what the doctor sees, not a summary version
Type of Information Patient Should See in EHR
29%
25%
30%
28%
23%
26%
34%
45%
71%
75%
70%
72%
77%
74%
66%
55%
2016
2016
2016
2016
2016
2016
2016
2016
Global
Australia
Brazil
England
Norway
Saudi Arabia
Singapore
US
Exactly what the doctor sees
Summary version of what doctor sees
BASE: SHOULD HAVE ACCESS TO EHR : Global Total n= 7684; Australia n= 997; Brazil n= 990; England n=981; Norway n= 787; Saudi Arabia n= 825; Singapore n= 901; US n= 2203
Q835. What information should you as a patient see in your electronic health record?
Copyright © 2016 Accenture. All rights reserved.
10
Most consumers report having at least limited access to
their EHR, although this varies greatly by country
Level of Access Patient Does Have to EHR
Any
Access
64%
46%
50%
45%
28%
23%
26%
64%
81%
79%
57%
61%
76%
40%
41%
49%
18%
19%
27%
24%
23%
27%
54%
24%
18%
19%
21%
24%
54%
49%
37%
36%
2016
2016
2016
2016
2016
2016
2016
2016
Global
Australia
Brazil
England
Norway
Saudi Arabia
Singapore
US
No access
Limited Access
Full Access
BASE: ALL QUALIFIED RESPONDENTS: Global Total n= 7840; Australia n= 1013; Brazil n= 1006; England n= 1009; Norway n= 800; Saudi Arabia n= 852; Singapore n= 935; US n= 2225
Q840. (D905/710) What level of access do you as a patient have to your electronic health record, created by your physician?
Copyright © 2016 Accenture. All rights reserved.
11
Consumers and doctors agree that patients should
update most information in their EHRs
Patient Should Update Some or All Information in EHR
Global
Consumers
Demographic
Information
Personal
medical
history
Family
medical
history
New
symptoms
Change in
symptoms
New
medications
Medication
side effects
Allergic
episodes
Lab test
results
Selfmeasured
metrics
Australia
Consumers
Doctors
Brazil
Consumers
England
Doctors
Consumers
Doctors
Norway
Consumers
Doctors
Saudi Arabia
Consumers
Doctors
Singapore
Consumers
Doctors
US
Consumers
Doctors
80%
79%
94%
82%
85%
70%
91%
68%
87%
76%
92%
86%
88%
86%
95%
79%
76%
81%
82%
81%
68%
76%
73%
81%
81%
92%
87%
85%
83%
90%
84%
81%
87%
84%
87%
76%
82%
73%
80%
83%
97%
90%
83%
89%
93%
83%
77%
79%
90%
84%
74%
70%
79%
80%
86%
41%
87%
89%
87%
83%
82%
79%
81%
88%
83%
74%
72%
75%
81%
84%
40%
86%
87%
86%
84%
73%
65%
79%
80%
84%
61%
67%
67%
73%
80%
38%
74%
85%
75%
88%
84%
80%
84%
88%
86%
76%
75%
81%
79%
85%
85%
88%
83%
84%
86%
83%
80%
84%
89%
90%
74%
74%
81%
85%
83%
58%
90%
86%
86%
88%
63%
54%
52%
77%
73%
55%
44%
59%
56%
74%
39%
69%
71%
57%
63%
79%
75%
82%
84%
81%
72%
78%
73%
84%
81%
40%
89%
92%
79%
83%
BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia
2016 n=852; Singapore 2016 n=935; US 2016 n=2225
Q880. (D910/712) How much of each of the following types of information should you, as a patient be able to update in your electronic personal health record?
*2015 Accenture Doctors Survey
Full data available in Appendix
Copyright © 2016 Accenture. All rights reserved.
12
Consumers and doctors agree that patients should
update demographic information in EHRs
Level of Patient Updating to Electronic Personal Health Record: Demographic information
Update
Any
80%
47%
79% 94%
45%
82% 85%
47%
70% 91%
32%
37%
56%
45%
35%
21%
21%
6%
Global
Australia
58%
72%
33% 32%
9%
England
Patient should not update
28%
26%
33%
30%
Brazil
53% 56%
36%
43%
29%
18% 15%
86% 95%
40%
66%
30%
28%
86% 88%
36%
33%
34%
76% 92%
62%
66%
33%
68% 87%
13%
Norway
Some information
24%
8%
Saudi Arabia
23%
13% 12%
Singapore
15%
US
All information
BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia
2016 n=852; Singapore 2016 n=935; US 2016 n=2225
Q880. (D910/712) How much of each of the following types of information should you, as a patient be able to update in your electronic personal health record?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
5%
13
Consumers and doctors agree that patients should
update personal medical history in EHRs
Level of Patient Updating to Electronic Personal Health Record: Personal medical history
Update
Any
79%
51%
76% 81%
48% 41%
82% 81%
57% 52%
68% 76%
73% 81%
41% 39%
44%
81% 92%
87% 85%
83% 90%
51%
52% 51%
57%
35% 34%
26% 40%
13% 15%
17%
34%
50%
74%
27%
28%
21%
Global
28% 40%
36%
29% 47%
30%
25% 29%
32%
25% 19%
18% 19%
Australia
Brazil
24%
England
Patient should not update
27%
18%
19%
Norway
Some information
19%
8%
Saudi Arabia
Singapore
10%
US
All information
BASE: ALL QUALIFIED RESPONDENTS : Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia
2016 n=852; Singapore 2016 n=935; US 2016 n=2225
Q880. (D910/712) How much of each of the following types of information should you, as a patient be able to update in your electronic personal health record?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
14
Consumers and doctors agree that patients should
update family medical history in EHRs
Level of Patient Updating to Electronic Personal Health Record: Family medical history
Update
Any
84%
81% 87%
51%
48% 51%
84% 87%
76%
82%
41% 43%
73% 80%
30% 37%
57% 59%
83% 97%
90% 83%
47%
52% 51%
89% 93%
61% 65%
77%
35%
33%
16%
Global
33%
36%
43%
39%
43%
36%
27% 28%
19% 13%
16% 13%
Australia
Brazil
38%
25%
18%
26% 20%
17%
20%
3%
England
Patient should not update
Norway
Some information
Saudi Arabia
10%
32%
28% 29%
17%
Singapore
10%
US
All information
BASE: ALL QUALIFIED RESPONDENTS : Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia
2016 n=852; Singapore 2016 n=935; US 2016 n=2225
Q880. (D910/712) How much of each of the following types of information should you, as a patient be able to update in your electronic personal health record?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
7%
15
Consumers and doctors agree that patients should
update new symptoms in EHRs
Level of Patient Updating to Electronic Personal Health Record: New symptoms
Update
Any
83%
55%
77% 79%
49%
90% 84%
43%
74%
46%
67%
70%
79% 80%
49%
33%
28%
16%
22% 21%
Global
Australia
9%
16%
Brazil
60%
30% 59%
34% 40%
27%
15%
12% 11%
14% 17%
Singapore
US
27%
56%
26% 30%
England
Patient should not update
46%
44%
30%
26%
23%
53% 49%
41%
14%
28%
28% 36%
87% 83%
36%
37%
58%
87% 89%
86%
21% 20%
Norway
Some information
Saudi Arabia
37%
All information
BASE: ALL QUALIFIED RESPONDENTS : Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia
2016 n=852; Singapore 2016 n=935; US 2016 n=2225
Q880. (D910/712) How much of each of the following types of information should you, as a patient be able to update in your electronic personal health record?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
16
Consumers and doctors agree that patients should
update changes in symptoms in EHRs
Level of Patient Updating to Electronic Personal Health Record: Changes in symptoms
Update
Any
82%
79%
52%
46% 42%
30%
81%
88% 83%
74%
43%
63%
72%
34%
75%
81%
42% 37%
55%
84% 40%
86% 87%
86% 84%
51% 51%
58%
29%
52%
11%
31%
33% 38%
37%
33% 44%
28%
25%
18%
21% 19%
12% 17%
Global
Australia
Brazil
26% 28%
England
Patient should not update
43%
25% 19%
Norway
Some information
41%
32% 60%
35% 36%
28%
16%
13% 13%
14% 16%
Singapore
US
Saudi Arabia
All information
BASE: ALL QUALIFIED RESPONDENTS : Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia
2016 n=852; Singapore 2016 n=935; US 2016 n=2225
Q880. (D910/712) How much of each of the following types of information should you, as a patient be able to update in your electronic personal health record?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
17
Consumers and doctors agree that patients should
update new medications in EHRs
Level of Patient Updating to Electronic Personal Health Record: New medications
Update
Any
73%
65% 79%
80% 84%
61%
67%
67% 73%
80% 38%
74% 85%
75% 88%
46%
51% 57%
27%
48%
25%
28%
Global
43% 49%
39% 40%
27%
39% 33%
21%
Australia
25%
27%
24% 27%
35%
19% 16%
Brazil
50%
60%
11%
22%
22%
30%
42% 47%
56% 56%
England
Patient should not update
33% 27%
Norway
Some information
30%
28%
62%
20%
Saudi Arabia
24%
31%
24%
26%
15%
Singapore
25%
12%
US
All information
BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia
2016 n=852; Singapore 2016 n=935; US 2016 n=2225
Q880. (D910/712) How much of each of the following types of information should you, as a patient be able to update in your electronic personal health record?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
18
Consumers and doctors agree that patients should
update medication side effects in EHRs
Level of Patient Updating to Electronic Personal Health Record: Medication side effects
Update
Any
84%
80% 84%
55%
50% 49%
29%
88% 86%
76%
75%
46% 43%
65% 61%
23%
20% 16%
12% 14%
Global
Australia
Brazil
88% 83%
84% 86%
54%
55% 55%
58%
33% 28%
26%
34%
51%
49%
45%
30%
26%
17%
85% 85%
69%
30% 32%
30% 36%
81% 79%
31%
16%
37%
24% 25%
20% 21%
15% 15%
12% 17%
16% 14%
England
Norway
Saudi Arabia
Singapore
US
Patient should not update
Some information
All information
BASE: ALL QUALIFIED RESPONDENTS : Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia
2016 n=852; Singapore 2016 n=935; US 2016 n=2225
Q880. (D910/712) How much of each of the following types of information should you, as a patient be able to update in your electronic personal health record?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
19
Consumers and doctors agree that patients should
update allergic episodes in EHRs
Level of Patient Updating to Electronic Personal Health Record: Allergic episodes
Update
Any
83%
80% 84%
54%
49% 55%
89% 90%
74%
74%
81% 85%
83% 58%
90% 86%
86% 88%
45% 46%
48% 51%
53% 47%
56% 55%
59% 53%
34% 31%
27% 35%
10% 14%
14% 12%
Singapore
US
64% 68%
10%
29%
31%
29% 28%
29%
33%
34%
30%
25% 23%
42%
26% 26%
16%
20% 16%
11% 10%
Global
Australia
Brazil
England
Patient should not update
20% 15%
Norway
Some information
17%
Saudi Arabia
All information
BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia
2016 n=852; Singapore 2016 n=935; US 2016 n=2225
Q880. (D910/712) How much of each of the following types of information should you, as a patient be able to update in your electronic personal health record?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
20
Many consumers and doctors say that patients should
update lab test results in EHRs, but with some more
resistance from doctors than on other types of information
Level of Patient Updating to Electronic Personal Health Record: Lab test results
Update
Any
63%
54% 52%
44%
36%
77% 73%
55%
44%
36%
59%
27%
29%
41%
52%
18%
45%
Brazil
45% 38%
42%
33%
24% 33%
15% 30%
24%
21%
61%
56%
41% 44%
23% 27%
Australia
57% 63%
10%
18%
19%
46% 48%
69% 71%
29%
19%
18%
50%
23%
28%
Global
74% 39%
22%
24%
38%
59% 56%
26%
England
Patient should not update
Norway
Some information
Saudi Arabia
32% 29%
Singapore
42% 37%
US
All information
BASE: ALL QUALIFIED RESPONDENTS : Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia
2016 n=852; Singapore 2016 n=935; US 2016 n=2225
Q880. (D910/712) How much of each of the following types of information should you, as a patient be able to update in your electronic personal health record?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
21
Consumers and doctors agree that patients should
update self-measured metrics in EHRs
Level of Patient Updating to Electronic Personal Health Record: Self-measured metrics
Update
Any
79%
75% 82%
49%
45% 43%
84% 81%
72%
78%
73% 84%
42% 41%
41% 40%
81% 40%
89% 92%
79% 83%
53% 52%
50% 46%
28%
30%
58%
Global
25%
18%
Australia
54%
12%
30% 37%
30% 39%
26%
21%
51%
32%
30%
16% 19%
28% 22%
Brazil
England
Patient should not update
27%
44%
16%
Norway
Some information
27% 60%
19%
Saudi Arabia
29% 36%
36% 40%
11%
8%
Singapore
21% 17%
US
All information
BASE: ALL QUALIFIED RESPONDENTS : Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia
2016 n=852; Singapore 2016 n=935; US 2016 n=2225
Q880. (D910/712) How much of each of the following types of information should you, as a patient be able to update in your electronic personal health record?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
22
Consumers see EHRs as tools for their doctors and
themselves, not to be shared with others (i.e.,
government, employers)
Who should have access to your EHR?
Global
Australia
Brazil
England
Norway
Saudi
Arabia
Singapore
US
My primary doctor
69%
79%
65%
71%
80%
51%
57%
75%
Me
60%
63%
63%
56%
61%
47%
50%
67%
Hospitals I visit
52%
59%
40%
59%
67%
42%
48%
51%
49%
56%
46%
50%
51%
40%
35%
55%
41%
47%
30%
35%
34%
27%
45%
52%
Urgent care centers I visit
32%
35%
33%
32%
44%
24%
23%
32%
A doctor performing a
procedure in another
country
29%
37%
31%
31%
30%
19%
22%
30%
My pharmacy
22%
24%
13%
22%
19%
23%
13%
28%
Family members
20%
16%
30%
10%
9%
22%
30%
22%
Caregiver
15%
15%
14%
10%
8%
17%
15%
20%
Retail clinics I visit
13%
10%
35%
6%
4%
8%
19%
9%
An overseas health
expert performing clinical
analysis
13%
15%
20%
11%
11%
18%
13%
8%
The government
6%
5%
4%
3%
2%
16%
12%
3%
My employer
4%
1%
7%
3%
3%
8%
5%
3%
Other doctors or
specialists
Anyone I give permission
to
BASE: ALL QUALIFIED RESPONDENTS: Global Total n= 7840; Australia n= 1013; Brazil n= 1006; England n= 1009; Norway n= 800; Saudi Arabia n= 852; Singapore n= 935; US n= 2225
Q825. Who should have access to your electronic health records?
Copyright © 2016 Accenture. All rights reserved.
23
Consumers using technology to manage their health
rely on websites in particular; in some countries use of
apps and wearables is up from 2014
Technology or Electronic Health Management Tools Used (Past Year)
Global
Australia
Brazil
England
Norway
Saudi
Arabia
Singapore
US
2016
2014
2016
2014
2016
2014
2016
2014
2016
2016
2014
2016
2014
2016
52%
50%
50%
58%
62%
45%
44%
57%
40%
44%
61%
50%
55%
57%
36%
15%
29%
30%
37%
13%
36%
33%
30%
40%
40%
44%
16%
33%
27%
11%
17%
29%
40%
9%
21%
22%
22%
41%
29%
26%
14%
21%
19%
6%
21%
29%
15%
6%
20%
15%
19%
14%
17%
23%
9%
21%
19%
19%
10%
20%
14%
13%
34%
56%
30%
20%
10%
17%
14%
12%
14%
30%
11%
15%
25%
16%
27%
40%
19%
18%
10%
32%
13%
27%
16%
8%
11%
18%
22%
10%
17%
11%
11%
16%
17%
18%
10%
12%
15%
5%
8%
19%
21%
10%
10%
18%
16%
24%
8%
10%
12%
12%
Remote
monitoring*
10%
N/A
5%
N/A
16%
N/A
6%
N/A
8%
12%
N/A
10%
N/A
8%
Other
2%
3%
2%
2%
2%
2%
2%
3%
4%
1%
1%
1%
2%
2%
None
10%
34%
17%
3%
8%
32%
12%
8%
17%
6%
4%
7%
22%
10%
Websites
Mobile
phone/tablet
app
Social media
Wearable
technology
Smart scales
EHRs
Online
support
communities
Remote
consultation
*Added in 2016
BASE: USES TECHNOLOGY TO MANAGE HEALTH: Global 2016 n=5130;Australia 2014 n=1011,2016 n=551; Brazil 2014 n=894,2016 n=916;
England 2014 n=1013,2016 n=466; Norway 2014 n=380,2016 n=421; Saudi Arabia 2016 n=680; Singapore 2014 n=567,2016 n=662; US 2014 n=1605,2016 n=1434
Q625. (Q126.) Which of the following technology or electronic health management tools have you used to manage your health in the past year?
NOTE: unweighted data
Copyright © 2016 Accenture. All rights reserved.
24
Fitness and diet/nutrition apps are the most popular
among health app users
Type of App(s) Used
Global
Australia
Brazil
England
Norway
Saudi
Arabia
Singapore
US
Fitness
55%
66%
55%
52%
39%
46%
54%
59%
Diet/Nutrition
53%
48%
68%
44%
52%
54%
42%
52%
Symptom navigator
24%
18%
25%
8%
11%
24%
20%
36%
Health or condition tracker
24%
20%
27%
21%
18%
28%
25%
25%
Patient portal app
22%
15%
32%
15%
22%
19%
12%
28%
Medication
tracker/reminder/manager
18%
15%
33%
12%
19%
18%
16%
12%
Chronic condition or
disease management
11%
10%
14%
9%
15%
17%
7%
10%
Something else
9%
12%
4%
13%
15%
10%
14%
6%
BASE: USED APPS IN PAST YEAR TO MANAGE HEALTH: Global Total n= 1824; Australia n= 160; Brazil n= 337; England n= 166; Norway n= 125; Saudi Arabia n= 271; Singapore n= 291; US n= 474
Q630. What type of app(s) have you used?
Copyright © 2016 Accenture. All rights reserved.
25
Consumers and doctors in Australia agree
that wearable health devices help patient engagement
Effect of Wearables On…
Consumer Perspective
Engagement with own health
Doctor* Perspective
22% 3%
75%
25% 4%
70%
33%
Patient/physician communication
27%
4%
68%
34%
Patient satisfaction
28%
5%
67%
19%2%
79%
21% 2%
77%
Accuracy of medical record
Understanding of health condition
Overall quality of care
22% 3%
28%
75%
4%
Reduction in cost of healthcare
46%
Monitoring the health of a loved one
24% 4%
13%
1%
67%
5%
3%
64%
5%
61%
29% 2%
49%
46%
69%
19%
35%
N/A
72%
Has no effect
86%
Hurts
Helps
BASE: ALL QUALIFIED RESPONDENTS (2016 n=1013)
Q660 (D1070) Do you think the use of wearable health devices (for monitoring glucose, heart rate, physical activity, sleep, or weight) helps, hurts or has no effect on …?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
26
Consumers and doctors in Brazil agree
that wearable health devices help patient engagement
Effect of Wearables On…
Consumer Perspective
Engagement with own health 7%6%
Accuracy of medical record
87%
Doctor* Perspective
3%
3%
94%
14% 6%
79%
19% 6%
Patient/physician communication 12% 8%
80%
16%5%
Patient satisfaction
12%5%
Understanding of health condition 8%7%
Overall quality of care
Reduction in cost of healthcare
15% 7%
25%
Monitoring the health of a loved one 9%5%
75%
79%
83%
12%4%
84%
85%
11%
4%
85%
78%
10%
65%
16%5%
34%
79%
20%
46%
N/A
85%
Has no effect
Hurts
Helps
BASE: ALL QUALIFIED RESPONDENTS (2016 n=1006)
Q660 (D1070) Do you think the use of wearable health devices (for monitoring glucose, heart rate, physical activity, sleep, or weight) helps, hurts or has no effect on …?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
27
Consumers and doctors in England agree
that wearable health devices help patient engagement
Effect of Wearables On…
Consumer Perspective
Engagement with own health
28%
7%
Accuracy of medical record
34%
Patient/physician communication
32%
Patient satisfaction
Understanding of health condition
Overall quality of care
Reduction in cost of healthcare
Monitoring the health of a loved one
7%
62%
8%
55%
8%
37%
65%
6%
51%
31%
12%
2%
60%
6%
38%
27%
65%
7%
30%
86%
8%
38%
62%
9%
53%
19% 4%
77%
22% 6%
56%
7%
Doctor* Perspective
33%
41%
4%
44%
63%
25%
31%
N/A
62%
Has no effect
72%
Hurts
Helps
BASE: ALL QUALIFIED RESPONDENTS (2016 n=1009)
Q660 (D1070) Do you think the use of wearable health devices (for monitoring glucose, heart rate, physical activity, sleep, or weight) helps, hurts or has no effect on …?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
28
Consumers and doctors in Norway agree
that wearable health devices help patient engagement
Effect of Wearables On…
Consumer Perspective
Engagement with own health
33%
7%
60%
Doctor* Perspective
26% 4%
70%
Accuracy of medical record
40%
7%
53%
35%
Patient/physician communication
37%
10%
53%
38%
50%
24% 5%
71%
24% 3%
73%
Patient satisfaction
Understanding of health condition
Overall quality of care
Reduction in cost of healthcare
Monitoring the health of a loved one
41%
31%
9%
8%
43%
55%
49%
61%
8%
49%
9%
6%
39%
36%
60%
5%
57%
2%
56%
59%
18%
26%
N/A
45%
Has no effect
5%
Hurts
Helps
BASE: ALL QUALIFIED RESPONDENTS (2016 n=800)
Q660 (D1070) Do you think the use of wearable health devices (for monitoring glucose, heart rate, physical activity, sleep, or weight) helps, hurts or has no effect on …?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
29
Consumers and doctors in Saudi Arabia agree that
wearable health devices help patient engagement
Effect of Wearables On…
Consumer Perspective
Engagement with own health
Accuracy of medical record
Patient/physician communication
Patient satisfaction
18% 8%
24%
6%
18% 6%
24% 5%
Understanding of health condition 12%6%
Overall quality of care
Reduction in cost of healthcare
Monitoring the health of a loved one
71%
76%
71%
83%
19% 7%
24%
74%
12%
18% 7%
73%
64%
Doctor* Perspective
5%11%
5%
6%
84%
89%
6%8%
87%
5%13%
82%
6%7%
87%
4%
6%
90%
1%
14%
85%
74%
Has no effect
Hurts
Helps
BASE: ALL QUALIFIED RESPONDENTS (2016 n=852)
Q660 (D1070) Do you think the use of wearable health devices (for monitoring glucose, heart rate, physical activity, sleep, or weight) helps, hurts or has no effect on …?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
30
Consumers and doctors in Singapore agree that
wearable health devices help patient engagement
Effect of Wearables On…
Consumer Perspective
Engagement with own health
Accuracy of medical record
Patient/physician communication
Patient satisfaction
16% 6%
78%
72%
26%
68%
32%
6%
Understanding of health condition 12%5%
Overall quality of care
11%8%
23% 6%
6%
23%
Reduction in cost of healthcare
33%
Monitoring the health of a loved one
14%5%
62%
82%
7%
Doctor* Perspective
40%
35%
12%
63%
8%
67%
72%
7%
33%
56%
43%
76%
5%
73%
21%
39%
N/A
81%
Has no effect
8%
22% 5%
27%
71%
81%
Hurts
Helps
BASE: ALL QUALIFIED RESPONDENTS (2016 n=935)
Q660 (D1070) Do you think the use of wearable health devices (for monitoring glucose, heart rate, physical activity, sleep, or weight) helps, hurts or has no effect on …?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
31
Consumers and doctors in the US agree
that wearable health devices help patient engagement
Effect of Wearables On…
Consumer Perspective
Engagement with own health
19% 4%
Accuracy of medical record
29%
Patient/physician communication
26%
Patient satisfaction
Understanding of health condition
Overall quality of care
Reduction in cost of healthcare
Monitoring the health of a loved one
77%
4%
31%
4%
20% 4%
29%
12%
3%
67%
5%
41%
22% 4%
85%
40%
69%
35%
64%
22% 5%
76%
4%
Doctor* Perspective
27%
67%
8%
57%
73%
7%
43%
66%
5%
62%
21%
36%
N/A
74%
Has no effect
52%
8%
33%
51%
8%
Hurts
Helps
BASE: ALL QUALIFIED RESPONDENTS (2016 n=2225)
Q660 (D1070) Do you think the use of wearable health devices (for monitoring glucose, heart rate, physical activity, sleep, or weight) helps, hurts or has no effect on …?
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
32
Many consumers wear or would be willing to wear
health tracking technology
Wears or Would Be Willing to Wear Technology to Track…
Global
Australia
Brazil
England
Norway
Saudi
Arabia
Singapore
US
2016
2014
2016
2014
2016
2014
2016
2014
2016
2016
2014
2016
2014
2016
Fitness and
lifestyle only
17%
11%
15%
26%
19%
12%
14%
19%
16%
24%
18%
18%
11%
15%
Vital signs
only
16%
12%
11%
18%
20%
15%
15%
18%
19%
23%
20%
16%
15%
12%
Both
45%
56%
49%
51%
55%
54%
44%
36%
27%
31%
49%
48%
50%
51%
Neither
22%
21%
25%
5%
6%
18%
27%
27%
38%
21%
13%
19%
24%
21%
BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2014 n=1020,2016 n=1013; Brazil 2014 n=1015,2016 n=1006; England 2014 n=1019,2016 n=1009;
Norway 2014 n=806,2016 n=800; Saudi Arabia 2016 n=852; Singapore 2014 n=806,2016 n=935; US 2014 n=2011,2016 n=2225
Q645. (Q151). Do you or would you be willing to wear technology that measures and tracks…?
NOTE: unweighted data
Copyright © 2016 Accenture. All rights reserved.
33
Some app users have discussed or shared app data
with their doctors (particularly in Brazil)
Discussed or Shared app Data with Doctor
16%
29%
30%
40%
30%
40%
43%
63%
84%
71%
70%
60%
70%
60%
57%
37%
2015
2015
2015
2015
2015
2015
2015
2015
Global
Australia
Brazil
England
Norway
Saudi Arabia
Singapore
US
No
Yes
BASE: USED APPS IN PAST YEAR TO MANAGE HEALTH: Global Total n= 1824; Australia n= 160; Brazil n= 337; England n= 166; Norway n= 125; Saudi Arabia n= 271; Singapore n= 291; US n= 474
Q635. Have you discussed or shared data from your app with your doctor or other medical provider?
Copyright © 2016 Accenture. All rights reserved.
34
Across all countries, fewer than half of consumers
report that a doctor recommended wearable technology
to track health
Doctor Has Recommended Wearable Technology to Track…
47%
43%
37%
31%
24%23%
19%
15%
16%16%
24%
20%
22%22%
19%18%
2016
2016
2016
2016
2016
2016
2016
2016
Global
Australia
Brazil
England
Norway
Saudi Arabia
Singapore
US
Vital signs
Fitness and lifestyle
BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800;
Saudi Arabia 2016 n=852; Singapore 2016 n=935; US 2016 n=2225
Q650. Has a doctor ever recommended that you wear technology to measure and track the following?
Copyright © 2016 Accenture. All rights reserved.
35
Among consumers whose doctor recommended
wearable technology, the majority took their doctor’s
advice
Took Doctor’s Advice to Use Wearable Technology
66%
74%
77%
80%
87%
34%
26%
23%
20%
13%
74%
70%
26%
30%
76%
24%
2016
2016
2016
2016
2016
2016
2016
2016
Global
Australia
Brazil
England
Norway
Saudi Arabia
Singapore
US
No
Yes
BASE: DOCTOR RECOMMENDED WEARABLE: Global Total n= 2279; Australia n= 217; Brazil n= 524; England n= 224; Norway n= 208; Saudi Arabia n= 372; Singapore n= 225; US n= 461
Q655. Did you take your doctor’s advice to wear technology to measure and track your fitness and lifestyle or vital signs?
Copyright © 2016 Accenture. All rights reserved.
36
The majority of consumers are willing to share wearable
and app data with their doctors…
Willingness to Share Wearable or Mobile App Data With…
Your doctor
Willing
85%
51%
89%
89%
52%
58%
84%
76%
50%
45%
76%
40%
87%
90%
35%
60%
35%
31%
35%
37%
31%
51%
34%
29%
7%
12%
17%
8%
6%
6%
5%
7%
4%
9%
11%
7%
2016
2016
2016
2016
2016
Global
Australia
Brazil
England
Norway
Not at all willing
Not very willing
2016
10%
3%
2016
2016
Saudi Arabia
Singapore
US
Somewhat willing
5%
5%
Very willing
BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia 2016
n=852; Singapore 2016 n=935; US 2016 n=2225
Q670. How willing would you be to share information from your wearable technology or mobile app (e.g., activity throughout the day, heart rate) with each of the following?
Copyright © 2016 Accenture. All rights reserved.
37
…their nurses or other healthcare professionals
Willingness to Share Wearable or Mobile App Data With…
Your nurse or other healthcare professional
Willing
80%
37%
81%
80%
33%
41%
79%
67%
67%
82%
28%
24%
25%
39%
48%
42%
39%
43%
47%
40%
87%
57%
40%
39%
17%
12%
10%
14%
9%
6%
10%
2016
2016
2016
2016
2016
Global
Australia
Brazil
England
Norway
Not very willing
15%
4%
6%
7%
2016
2016
2016
Saudi Arabia
Singapore
US
16%
8%
Not at all willing
23%
11%
10%
Somewhat willing
Very willing
BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia 2016
n=852; Singapore 2016 n=935; US 2016 n=2225
Q670. How willing would you be to share information from your wearable technology or mobile app (e.g., activity throughout the day, heart rate) with each of the following?
Copyright © 2016 Accenture. All rights reserved.
38
Many consumers are willing to share wearable or app
data with their health insurance plan, more so in certain
countries (i.e., Brazil)
Willingness to Share Wearable or Mobile App Data With…
Your health insurance plan
Willing
56%
18%
47%
11%
71%
40%
11%
43%
62%
23%
30%
23%
31%
45%
38%
39%
44%
23%
26%
25%
19%
28%
37%
40%
24%
23%
21%
63%
10%
12%
27%
36%
55%
33%
18%
33%
10%
13%
12%
18%
2016
2016
2016
2016
2016
2016
2016
2016
Global
Australia
Brazil
England
Norway
Saudi Arabia
Singapore
US
Not at all willing
Not very willing
Somewhat willing
Very willing
BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia 2016
n=852; Singapore 2016 n=935; US 2016 n=2225
Q670. How willing would you be to share information from your wearable technology or mobile app (e.g., activity throughout the day, heart rate) with each of the following?
Copyright © 2016 Accenture. All rights reserved.
39
Consumers are willing to share wearable and app data
with friends or family members
Willingness to Share Wearable or Mobile App Data With…
Friend or family member
Willing
69%
70%
26%
25%
79%
62%
22%
51%
16%
67%
78%
24%
25%
37%
72%
30%
35%
40%
43%
43%
45%
53%
41%
42%
26%
19%
17%
21%
17%
12%
19%
15%
17%
23%
13%
13%
2016
2016
2016
2016
2016
2016
2016
2016
Global
Australia
Brazil
England
Norway
Saudi Arabia
Singapore
US
12%
8%
Not at all willing
Not very willing
Somewhat willing
5%
13%
Very willing
BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia 2016
n=852; Singapore 2016 n=935; US 2016 n=2225
Q670. How willing would you be to share information from your wearable technology or mobile app (e.g., activity throughout the day, heart rate) with each of the following?
Copyright © 2016 Accenture. All rights reserved.
40
Willing
Most consumers are hesitant to share data with other
app users or online community members
Willingness to Share Wearable or Mobile App Data With…
Online community/other app users
38%
11%
30%
7%
61%
27%
6%
24%
21%
23%
22%
4%
50%
13%
38%
6%
32%
27%
37%
24%
37%
11%
17%
28%
29%
38%
26%
23%
27%
41%
31%
23%
35%
47%
41%
54%
39%
17%
19%
21%
2016
2016
2016
2016
2016
2016
2016
2016
Global
Australia
Brazil
England
Norway
Saudi Arabia
Singapore
US
Not at all willing
Not very willing
Somewhat willing
Very willing
BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia 2016
n=852; Singapore 2016 n=935; US 2016 n=2225
Q670. How willing would you be to share information from your wearable technology or mobile app (e.g., activity throughout the day, heart rate) with each of the following?
Copyright © 2016 Accenture. All rights reserved.
41
Consumers are not willing to share wearable and app
data with their employers
Willingness to Share Wearable or Mobile App Data With…
Your employer
Willing
34%
10%
54%
22%
7%
17%
16%
26%
8%
18%
24%
44%
24%
8%
11%
38%
7%
31%
10%
17%
32%
21%
32%
37%
30%
27%
27%
26%
29%
33%
40%
27%
47%
46%
37%
49%
43%
19%
23%
21%
2016
2016
2016
2016
2016
2016
2016
2016
Global
Australia
Brazil
England
Norway
Saudi Arabia
Singapore
US
Not at all willing
Not very willing
Somewhat willing
Very willing
BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2016 n=1013; Brazil 2016 n=1006; England 2016 n=1009; Norway 2016 n=800; Saudi Arabia 2016
n=852; Singapore 2016 n=935; US 2016 n=2225
Q670. How willing would you be to share information from your wearable technology or mobile app (e.g., activity throughout the day, heart rate) with each of the following?
Copyright © 2016 Accenture. All rights reserved.
42
Consumers and doctors in Australia associate
virtual visits with convenience and lower costs,
but in-person visits with quality care
Advantages of Virtual or In-Person Visits: Australia
Percent Ranking Top 3 for In-Person and Virtual
Consumers
Doctors*
In-Person
Providing quality care to patients
69%
11%
51%
Diagnosing problems faster
Engaging patients in their
health/healthcare decisions
30%
50%
19%
29%
35%
Providing timely care to patients
Reducing potential (or number of)
adverse events
19%
Accommodating physicians' schedules
19%
Providing quality care to patients
Diagnosing problems faster
82%
56%
11%
54%
20%
42%
9%
Accommodating physicians'
schedule
27%
31%
24%
Providing timely care to patients
46%
41%
16%
60%
Virtual
8%
Engaging patients in decisions
Reducing adverse events
28%
28%
Accommodating patients' schedules
Reducing medical costs to patients
In-Person
Virtual
52%
Accommodating patients'
schedules
5%
Reducing medical costs to
patients
5%
80%
72%
BASE: ALL QUALIFIED RESPONDENTS (n=1013)
Q760. (D1035) From the list below, please select the top three advantages of in-person patient visits and the top three advantages of remote or virtual visits.
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
43
Consumers and doctors in Brazil associate
virtual visits with convenience and lower costs,
but in-person visits with quality care
Advantages of Virtual or In-Person Visits: Brazil
Percent Ranking Top 3 for In-Person and Virtual
Consumers
Doctors*
In-Person
Providing quality care to patients
Engaging patients in their health/healthcare
decisions
Virtual
68%
10%
59%
13%
44%
Diagnosing problems faster
Reducing potential (or number of) adverse
events
Accommodating physicians' schedules
31%
37%
18%
Reducing medical costs to patients
15%
Providing timely care to patients
14%
Engaging patients in decisions
Reducing adverse events
54%
50%
54%
Accommodating physicians'
schedule
Virtual
88%
4%
59%
12%
54%
12%
53%
17%
17%
Providing timely care to patients
42%
16%
Providing quality care to patients
Diagnosing problems faster
20%
Accommodating patients' schedules
In-Person
42%
11%
66%
Accommodating patients'
schedules
6%
Reducing medical costs to
patients
5%
73%
63%
BASE: ALL QUALIFIED RESPONDENTS BASE: ALL QUALIFIED RESPONDENTS (n=1006)
Q760. (D1035) From the list below, please select the top three advantages of in-person patient visits and the top three advantages of remote or virtual visits.
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
44
Doctors in England are more likely to see
reducing adverse events as a top advantage of
in-person visits vs. patients
Advantages of Virtual or In-Person Visits: England
Percent Ranking Top 3 for In-Person and Virtual
Consumers
Doctors*
In-Person
Providing quality care to patients
Virtual
61%
13%
49%
Diagnosing problems faster
Engaging patients in their health/healthcare
decisions
30%
46%
22%
35%
30%
Providing timely care to patients
Reducing potential (or number of) adverse
events
20%
Accommodating physicians' schedules
20%
Reducing medical costs to patients
Providing quality care to patients
83%
63%
15%
53%
Engaging patients in decisions
20%
46%
7%
Accommodating physicians'
schedule
41%
50%
15%
46%
27%
43%
14%
Providing timely care to patients
Accommodating patients'
schedules
Reducing medical costs to
patients
Virtual
5%
Diagnosing problems faster
Reducing adverse events
26%
30%
Accommodating patients' schedules
In-Person
54%
5%
81%
3%
59%
BASE: ALL QUALIFIED RESPONDENTS (n=1009)
Q760. (D1035) From the list below, please select the top three advantages of in-person patient visits and the top three advantages of remote or virtual visits.
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
45
Although consumers and doctors in Norway associate
virtual visits with scheduling convenience, many see
timely care as an advantage of in-person visits
Advantages of Virtual or In-Person Visits: Norway
Percent Ranking Top 3 for In-Person and Virtual
Consumers
Doctors*
In-Person
Providing quality care to patients
Virtual
Providing quality care to patients
Reducing medical costs to patients
69%
Diagnosing problems faster
14%
39%
39%
32%
Engaging patients in decisions
25%
Engaging patients in their health/healthcare
decisions
Accommodating patients' schedules
83%
3%
49%
32%
Providing timely care to patients
Accommodating physicians' schedules
Virtual
67%
10%
Diagnosing problems faster
Reducing potential (or number of) adverse
events
In-Person
37%
28%
36%
26%
Providing timely care to patients
33%
Reducing adverse events
18%
19%
33%
10%
Accommodating physicians'
schedule
39%
16%
50%
10%
58%
24%
38%
Accommodating patients'
schedules
3%
Reducing medical costs to
patients
3%
80%
79%
BASE: BASE: ALL QUALIFIED RESPONDENTS (n=800)
Q760. (D1035) From the list below, please select the top three advantages of in-person patient visits and the top three advantages of remote or virtual visits.
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
46
Consumers and doctors in Saudi Arabia associate
in-person visits with quality care; consumers see
virtual as cost-effective
Advantages of Virtual or In-Person Visits: Saudi Arabia
Percent Ranking Top 3 for In-Person and Virtual
Consumers
Doctors*
In-Person
Providing quality care to patients
Diagnosing problems faster
Engaging patients in their health/healthcare
decisions
In-Person
Virtual
48%
21%
47%
26%
36%
28%
Engaging patients in decisions
Providing timely care to patients
33%
33%
Diagnosing problems faster
Reducing potential (or number of) adverse
events
32%
29%
Reducing medical costs to
patients
Accommodating patients' schedules
25%
Accommodating physicians' schedules
25%
Reducing medical costs to patients
Providing timely care to patients
37%
Accommodating physicians'
schedule
37%
23%
50%
55%
22%
43%
35%
Providing quality care to patients
Reducing adverse events
Accommodating patients'
schedules
Virtual
41%
23%
35%
33%
32%
33%
29%
51%
25%
34%
22%
47%
BASE: BASE: ALL QUALIFIED RESPONDENTS (n=852)
Q760. (D1035) From the list below, please select the top three advantages of in-person patient visits and the top three advantages of remote or virtual visits.
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
47
Consumers and doctors in Singapore associate
virtual visits with convenience and lower costs, but inperson visits with quality care and patient engagement
Advantages of Virtual or In-Person Visits: Singapore
Percent Ranking Top 3 for In-Person and Virtual
Consumers
Doctors*
In-Person
Providing quality care to patients
Diagnosing problems faster
Engaging patients in their health/healthcare
decisions
Virtual
64%
13%
55%
23%
53%
19%
Reducing potential (or number of) adverse
events
29%
22%
Providing timely care to patients
28%
Accommodating physicians' schedules
16%
Reducing medical costs to patients
16%
Providing quality care to patients
Diagnosing problems faster
Engaging patients in decisions
Reducing adverse events
41%
Providing timely care to patients
40%
Accommodating physicians'
schedule
19%
Accommodating patients' schedules
In-Person
56%
58%
Virtual
62%
14%
61%
21%
46%
21%
43%
23%
32%
38%
26%
40%
Reducing medical costs to
patients
15%
Accommodating patients'
schedules
14%
67%
68%
BASE: BASE: ALL QUALIFIED RESPONDENTS (n=935)
Q760. (D1035) From the list below, please select the top three advantages of in-person patient visits and the top three advantages of remote or virtual visits.
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
48
Consumers and doctors in the US associate
virtual visits with convenience and lower costs,
but in-person visits with quality care
Advantages of Virtual or In-Person Visits: US
Percent Ranking Top 3 for In-Person and Virtual
Consumers
Doctors*
In-Person
Providing quality care to patients
Engaging patients in their health/healthcare
decisions
Virtual
68%
11%
50%
17%
48%
Diagnosing problems faster
Reducing potential (or number of) adverse
events
Providing timely care to patients
Accommodating physicians' schedules
Accommodating patients' schedules
Reducing medical costs to patients
29%
32%
In-Person
Providing quality care to patients
Diagnosing problems faster
25%
81%
7%
54%
15%
50%
Engaging patients in decisions
Reducing adverse events
20%
20%
43%
12%
30%
37%
Accommodating physicians' schedule
42%
21%
22%
Providing timely care to patients
41%
18%
52%
15%
58%
Virtual
49%
Accommodating patients' schedules
8%
Reducing medical costs to patients
7%
80%
62%
BASE: BASE: ALL QUALIFIED RESPONDENTS (n=2225)
Q760. (D1035) From the list below, please select the top three advantages of in-person patient visits and the top three advantages of remote or virtual visits.
*2015 Accenture Doctors Survey
Copyright © 2016 Accenture. All rights reserved.
49
Overall, the majority of consumers continue to prefer inperson visits over remote
Prefer Remote or In-Person Visits
58%
70%
71%
86%
82%
65%
76%
76%
24%
24%
80%
42%
30%
29%
14%
18%
35%
20%
23%
2016
2014 2016
2014 2016
2014 2016
2014 2016
Global
Australia
Brazil
England
Norway
Remote
67%
77%
2016
33%
72%
28%
2014 2016
Saudi Arabia Singapore
77%
23%
71%
29%
2014 2016
US
In-person
BASE: ALL QUALIFIED RESPONDENTS: Global 2016 n=7840;Australia 2014 n=1020,2016 n=1013; Brazil 2014 n=1015,2016 n=1006; England 2014
n=1019,2016 n=1009; Norway 2014 n=806,2016 n=800; Saudi Arabia 2016 n=852; Singapore 2014 n=806,2016 n=935; US 2014 n=2011,2016 n=2225
Q750. (Q199). Which of the following is closer to your view?
NOTE: unweighted data
Copyright © 2016 Accenture. All rights reserved.
50
51